106981-51-5 Usage
Uses
Used in Organic Synthesis:
5-Amino-2-(1H-pyrrol-1-yl)benzonitrile is used as an intermediate in the production of various pharmaceuticals and organic compounds. Its unique structure allows for the creation of a wide range of molecules with diverse properties and applications.
Used in Research and Development:
In the field of research and development, 5-Amino-2-(1H-pyrrol-1-yl)benzonitrile is explored for its potential therapeutic properties. Its specific applications may vary depending on the context, but its presence in the development of new drugs and treatments highlights its importance in advancing medical science.
Used in Pharmaceutical Industry:
5-Amino-2-(1H-pyrrol-1-yl)benzonitrile is used as a key component in the synthesis of pharmaceuticals for various therapeutic areas. Its ability to be modified and incorporated into different molecular structures makes it a valuable asset in drug discovery and development processes.
Used in Chemical Research:
In chemical research, 5-Amino-2-(1H-pyrrol-1-yl)benzonitrile serves as a model compound for studying the properties and reactions of benzene derivatives with amino and nitrile functional groups. This helps in understanding the reactivity and potential applications of similar compounds in various chemical reactions and processes.
Check Digit Verification of cas no
The CAS Registry Mumber 106981-51-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,6,9,8 and 1 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 106981-51:
(8*1)+(7*0)+(6*6)+(5*9)+(4*8)+(3*1)+(2*5)+(1*1)=135
135 % 10 = 5
So 106981-51-5 is a valid CAS Registry Number.
InChI:InChI=1/C11H9N3/c12-8-9-7-10(13)3-4-11(9)14-5-1-2-6-14/h1-7H,13H2
106981-51-5Relevant academic research and scientific papers
VEGFR TYROSINE KINASE INHIBITORS
-
Page/Page column 30, (2014/12/12)
Novel compounds, their prodrugs, and the pharmaceutically acceptable salts as pharmaceutical compositions containing such compounds useful in treating certain diseases modulated by the inhibition of vascular endothelial growth factors (VEGFs) receptor tyrosine kinases are provided. In particular, compounds and compositions and the methods for the prophylaxis, management and treatment of cancers through the inhibition of VEGF receptor tyrosine kinases are provided.
